<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><submitter>He T</submitter><funding>NCI NIH HHS</funding><pubmed_abstract>The POU2F3-POU2AF2/3 (OCA-T1/2) transcription factor complex is the master regulator of the tuft cell lineage and tuft cell-like small cell lung cancer (SCLC). Here, we found that the POU2F3 molecular subtype of SCLC (SCLC-P) exhibits an exquisite dependence on the activity of the mammalian switch/sucrose non-fermentable (mSWI/SNF) chromatin remodeling complex. SCLC-P cell lines were sensitive to nanomolar levels of a mSWI/SNF ATPase proteolysis targeting chimera (PROTAC) degrader when compared to other molecular subtypes of SCLC. POU2F3 and its cofactors were found to interact with components of the mSWI/SNF complex. The POU2F3 transcription factor complex was evicted from chromatin upon mSWI/SNF ATPase degradation, leading to attenuation of downstream oncogenic signaling in SCLC-P cells.</pubmed_abstract><journal>bioRxiv : the preprint server for biology</journal><pagination>2024.01.22.576669</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10849552</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Targeting the mSWI/SNF Complex in POU2F-POU2AF Transcription Factor-Driven Malignancies.</pubmed_title><pmcid>PMC10849552</pmcid><funding_grant_id>R35 CA231996</funding_grant_id><funding_grant_id>P50 CA186786</funding_grant_id><pubmed_authors>Young E</pubmed_authors><pubmed_authors>Ching-Yi Tien J</pubmed_authors><pubmed_authors>Samajdar S</pubmed_authors><pubmed_authors>Hou S</pubmed_authors><pubmed_authors>Kim N</pubmed_authors><pubmed_authors>Su F</pubmed_authors><pubmed_authors>Zheng H</pubmed_authors><pubmed_authors>Miner SJ</pubmed_authors><pubmed_authors>Mehra R</pubmed_authors><pubmed_authors>Wang X</pubmed_authors><pubmed_authors>Parolia A</pubmed_authors><pubmed_authors>Wu XS</pubmed_authors><pubmed_authors>Zheng Y</pubmed_authors><pubmed_authors>Mahapatra S</pubmed_authors><pubmed_authors>Abbineni C</pubmed_authors><pubmed_authors>Chinnaiyan AM</pubmed_authors><pubmed_authors>Eyunni S</pubmed_authors><pubmed_authors>Qiao Y</pubmed_authors><pubmed_authors>He T</pubmed_authors><pubmed_authors>Xiao L</pubmed_authors><pubmed_authors>Mannan R</pubmed_authors><pubmed_authors>Cao X</pubmed_authors><pubmed_authors>Klingbeil O</pubmed_authors><pubmed_authors>Vakoc CR</pubmed_authors><pubmed_authors>Ramachandra M</pubmed_authors></additional><is_claimable>false</is_claimable><name>Targeting the mSWI/SNF Complex in POU2F-POU2AF Transcription Factor-Driven Malignancies.</name><description>The POU2F3-POU2AF2/3 (OCA-T1/2) transcription factor complex is the master regulator of the tuft cell lineage and tuft cell-like small cell lung cancer (SCLC). Here, we found that the POU2F3 molecular subtype of SCLC (SCLC-P) exhibits an exquisite dependence on the activity of the mammalian switch/sucrose non-fermentable (mSWI/SNF) chromatin remodeling complex. SCLC-P cell lines were sensitive to nanomolar levels of a mSWI/SNF ATPase proteolysis targeting chimera (PROTAC) degrader when compared to other molecular subtypes of SCLC. POU2F3 and its cofactors were found to interact with components of the mSWI/SNF complex. The POU2F3 transcription factor complex was evicted from chromatin upon mSWI/SNF ATPase degradation, leading to attenuation of downstream oncogenic signaling in SCLC-P cells.</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 May</publication><modification>2026-04-08T15:32:08.322Z</modification><creation>2025-04-19T21:08:20.639Z</creation></dates><accession>S-EPMC10849552</accession><cross_references><pubmed>38328238</pubmed><doi>10.1101/2024.01.22.576669</doi></cross_references></HashMap>